Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

Literature DB >> 978389

Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

P H Hinderling, E R Garrett.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Pyridines
Disopyramide

Year: 1976 PMID： 978389 DOI： 10.1007/BF01063614

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

22 in total

1. Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine.

Authors: T C Hutsell; S J Stachelski
Journal: J Chromatogr Date: 1975-03-19

2. A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors: D Du Bois; E F Du Bois
Journal: Nutrition Date: 1989 Sep-Oct Impact factor: 4.008

3. Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion.

Authors: G Härtel; A Louhija; A Konttinen
Journal: Clin Pharmacol Ther Date: 1974-06 Impact factor: 6.875

4. Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.

Authors: L A Vismara; D T Mason; E A Amsterdam
Journal: Clin Pharmacol Ther Date: 1974-08 Impact factor: 6.875

5. Route of administration and drug metabolism.

Authors: M Gibaldi; S Feldman
Journal: Eur J Pharmacol Date: 1972-09 Impact factor: 4.432

6. Influence of route of administration on drug availability.

Authors: M Rowland
Journal: J Pharm Sci Date: 1972-01 Impact factor: 3.534

7. Integral coefficients of multi-compartment pharmacokinetic models. Application to chemotherapy.

Authors: W J Jusko; G P Lewis; L W Dittert
Journal: Chemotherapy Date: 1972 Impact factor: 2.544

8. Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.

Authors: M Gibaldi; S Feldman
Journal: J Pharm Sci Date: 1969-12 Impact factor: 3.534

9. [A new antiarrhythmic agent: disopyramide].

Authors: J Granier
Journal: Presse Med Date: 1968-09-07 Impact factor: 1.228

10. A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE.

Authors: A SEKIYA; E M VAUGHANWILLIAMS
Journal: Br J Pharmacol Chemother Date: 1963-12

43 in total

Review 1. Nonlinear pharmacokinetics: clinical Implications.

Authors: T M Ludden
Journal: Clin Pharmacokinet Date: 1991-06 Impact factor: 6.447

Review 2. Therapeutic drug monitoring: antiarrhythmic drugs.

Authors: T J Campbell; K M Williams
Journal: Br J Clin Pharmacol Date: 1998-10 Impact factor: 4.335

3. Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: correlation of the kinetics of the drug and its effects.

Authors: P H Hinderling; E R Garrett
Journal: J Pharmacokinet Biopharm Date: 1976-06

4. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.

Authors: J L Cunningham; D D Shen; I Shudo; D L Azarnoff
Journal: Clin Pharmacokinet Date: 1977 Sep-Oct Impact factor: 6.447

5. A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.

Authors: H K Jones; H C Kelly; M Hutchison; R A Yates; F Ross; C Lomax; S Freestone; D Webb
Journal: Eur J Drug Metab Pharmacokinet Date: 1997 Jul-Sep Impact factor: 2.441

6. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.

Authors: S M Bryson; B Whiting; J R Lawrence
Journal: Br J Clin Pharmacol Date: 1978-11 Impact factor: 4.335

7. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.

Authors: K M Giacomini; T F Blaschke
Journal: Clin Pharmacokinet Date: 1984-01 Impact factor: 6.447